Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Suven Pharmaceuticals Ltd - 543064 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Friday, The 30Th October, 2020

 Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2020 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Friday, the 30th October, 2020 at 11:30 a.m. at the Registered Office, SDE Serene Chambers, 3rd Floor, Road No 5, Banjara Hills, Hyderabad - 500034 of the Company, to consider, inter alia, and approve the following matter(s): The Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the quarter and half-year ended September 30, 2020 and related matters Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st October, 2020 as per PIT Code of the Company. Trading window will be opened from 3rd November, 2020.
23-10-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 049490 Name of the Signatory :- K Hanumantha RaoDesignation :- Company Secretary and Compliance Officer
20-10-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Half-Year Ended 30Th September, 2020

 With reference to the above subject, please find enclosed compliance certificate for the half-year ended 30th September, 2020 duly signed by the Compliance Officer and authorised representative of the Share Transfer Agent (KFin Technologies Private Limited, Hyderabad), under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
15-10-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Submission Of Compliance Certificate Under Regulation 40(10) For The Half-Year Ended 30Th September, 2020

 With reference to above subject, please find enclosed Compliance Certificate for the half-year ended 30th September, 2020 issued by the Practicing Company Secretary, under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
15-10-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Shareholding for the Period Ended September 30, 2020

 Suven Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
13-10-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, please find enclosed herewith the Confirmation Certificate issued by KFin Technologies Private Limited, Registrar and Share Transfer Agents of the Company, for the quarter ended September 30, 2020
08-10-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Closure of Trading Window

 We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 1st October, 2020 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter/half-year ending 30th September, 2020, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
30-09-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Allotment

 In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the company, at its meeting held today i.e. September 29, 2020 at 5:15 p.m., has approved the allotment of 127282478 equity shares of Rs. 1.00 each as fully paid-up bonus equity shares, in the ratio of (1:1) one equity share for every one equity share held, to eligible members whose names appeared in the Register of Members/list of beneficial owners provided by the Depositories/RTA as on September 28, 2020, being the record date fixed for this purpose. Consequently, the paid-up equity share capital of the company stands increased to the following:
29-09-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received intimation from our RTA (KFin Technologies Private Limited) regarding loss of share certificate(s) from the following shareholders(s). A copy of intimation from RTA is enclosed herewith.
25-09-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Outcome Of The Board Meeting - Intimation Of Record Date Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 With reference to the above subject, pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. September 16, 2020, has approved and fixed the Record Date for the purpose of determining eligibility of the shareholders for Bonus Issue of Equity Shares of the Company. The disclosure of the Record Date in the tabular format is as below: Scrip Code and ID/ Scrip Symbol Type of security Book Closure both days inclusive Record date Purpose 1. BSE: Scrip Code: 543064 2. NSE Scrip Symbol: SUVENPHAR Equity shares Not Applicable September 28, 2020 Bonus issue (1:1) '1 (One) new fully paid up Equity Share of face value of INR 1/- (Rupee One Only) each of Suven Pharmaceuticals Limited shall be issued and allotted for every 1 (One) existing fully paid up equity share of face value of INR 1/- (Rupee One Only) each of the Company'
16-09-2020
Next Page
Close

Let's Open Free Demat Account